# Johnson & Johnson (JNJ) — Q3-2023 Earnings Results

**Report date:** 2023-10-17 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2023

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.66 | N/A | +5.39% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future performance. They emphasized the strength of their product pipeline.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They expressed confidence in long-term growth despite current market challenges.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report indicates that Johnson & Johnson has exceeded expectations on EPS, which may reflect operational efficiency or strong product demand. However, the lack of revenue data and guidance could leave investors uncertain about future performance. The stock reaction is not available, but the positive EPS surprise suggests some investor confidence.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2023_